KOPS - The Institutional Repository of the University of Konstanz

The efficacy of Narrative Exposure Therapy for Children (KIDNET) as a treatment for traumatized young refugees versus treatment as usual: update to the study protocol for the multi-center randomized controlled trial YOURTREAT

The efficacy of Narrative Exposure Therapy for Children (KIDNET) as a treatment for traumatized young refugees versus treatment as usual: update to the study protocol for the multi-center randomized controlled trial YOURTREAT

Cite This

Files in this item

Checksum: MD5:01ef1ff134222088457ee6e15e50276b

WITTMANN, Jasmin, Melissa GROSS, Claudia CATANI, Telja SCHMIDT, Sina NELDNER, Sarah WILKER, Theodor MAY, Verena ERTL, Rita ROSNER, Areej ZINDLER, Michael ODENWALD, Frank NEUNER, 2022. The efficacy of Narrative Exposure Therapy for Children (KIDNET) as a treatment for traumatized young refugees versus treatment as usual: update to the study protocol for the multi-center randomized controlled trial YOURTREAT. In: Trials. BioMed Central. 23(1), 360. ISSN 1468-6708. eISSN 1745-6215. Available under: doi: 10.1186/s13063-022-06288-8

@article{Wittmann2022-04-27effic-57499, title={The efficacy of Narrative Exposure Therapy for Children (KIDNET) as a treatment for traumatized young refugees versus treatment as usual: update to the study protocol for the multi-center randomized controlled trial YOURTREAT}, year={2022}, doi={10.1186/s13063-022-06288-8}, number={1}, volume={23}, issn={1468-6708}, journal={Trials}, author={Wittmann, Jasmin and Groß, Melissa and Catani, Claudia and Schmidt, Telja and Neldner, Sina and Wilker, Sarah and May, Theodor and Ertl, Verena and Rosner, Rita and Zindler, Areej and Odenwald, Michael and Neuner, Frank}, note={Article Number: 360} }

Ertl, Verena Schmidt, Telja Groß, Melissa Odenwald, Michael Neuner, Frank Ertl, Verena Odenwald, Michael eng Wilker, Sarah Rosner, Rita Background: The trial YOURTREAT aims to compare the pragmatic, short-term psychotherapy Narrative Exposure Therapy for Children (KIDNET) with treatment as usual (TAU) for the treatment of young refugees in Germany. This update outlines changes made to the study protocol in response to the current COVID-19 pandemic with the aim of allowing the continuation of the clinical trial while ensuring the safety of the staff and the participants, maintaining methodological quality, and ensuring compliance with legal regulations.<br />Methods: The major amendments to the original study protocol include (1) the possibility of using telehealth technology for the conduction of diagnostic and therapy sessions, (2) a reduction of the diagnostic set, and (3) an increased flexibility in the time frame of the study protocol.<br />Discussion: The adaptations to the study protocol made it feasible to continue with the trial YOURTREAT during the COVID-19 pandemic. Although the diagnostic set had to be shortened, the primary outcomes and the main secondary outcomes remain unimpaired by the amendment. Therefore, we expect the trial to provide evidence regarding effective treatment options for young refugees in Germany, a population that has received little scientific attention so far and has only very limited access to mental health care in the German health care system. In light of the current pandemic, which globally increases the risk of mental problems, the situation for young refugees is likely to aggravate further. Thus, the clinical and social relevance of the present trial YOURTREAT is even more important in these particular times. May, Theodor Rosner, Rita Schmidt, Telja Attribution 4.0 International Zindler, Areej Groß, Melissa Wilker, Sarah Neuner, Frank May, Theodor 2022-04-27 Neldner, Sina Neldner, Sina Catani, Claudia 2022-05-11T12:39:57Z Zindler, Areej 2022-05-11T12:39:57Z The efficacy of Narrative Exposure Therapy for Children (KIDNET) as a treatment for traumatized young refugees versus treatment as usual: update to the study protocol for the multi-center randomized controlled trial YOURTREAT Wittmann, Jasmin Catani, Claudia Wittmann, Jasmin

Downloads since May 11, 2022 (Information about access statistics)

Wittmann_2-x78cfbevqf3s5.pdf 18

This item appears in the following Collection(s)

Attribution 4.0 International Except where otherwise noted, this item's license is described as Attribution 4.0 International

Search KOPS


Browse

My Account